Pharmaceutical Business review

Omnicell Q1 revenue climbs

The company has posted net loss of $670,000, compared to $979,000 for the same period last year.

For the first quarter of 2011, Omnicell‘s loss from operations was $1.03m, compared to $1.51m for the same period in 2010.

Omnicell president, chairman and CEO Randall Lipps said the first quarter of 2011 met their expectations, and he am pleased with their performance.

"As announced earlier today, we are excited to bring to the market our innovative fourth-generation platform, highlighted by a single unified database for medications maintained in automated dispensing cabinets, as well as the first cabinet console to leverage Microsoft Windows 7 to boost reliability, security and performance," Lipps said.